Research News and Research

RSS

First U.S. transcatheter aortic heart valve implant performed at NewYork-Presbyterian/Columbia

NewYork-Presbyterian Hospital/Columbia University Medical Center today became the first in the United States to implant the SAPIEN transcatheter aortic heart valve as an FDA-approved standard of care.

5 Nov 2011

Toxoplasma gondii directly affects production of dopamine in brain

A research group from the University of Leeds has shown that infection by the brain parasite Toxoplasma gondii, found in 10-20 per cent of the UK's population, directly affects the production of dopamine, a key chemical messenger in the brain.

5 Nov 2011

Rothman researchers to develop gold standard definition for periprosthetic joint infection

A rise in periprosthetic joint infection (PJI) rates has the orthopedic community moving to develop it's first-ever agreed upon definition and diagnostic criteria to help better treat patients.

5 Nov 2011

Study finds increase in cervical cancer incidence among young British women

The incidence of cervical cancer in women in their 20s has risen by over 40 per cent between 1992 and 2006 in England, despite the overall incidence of cervical cancer dropping by 30 per cent, according to research that will be presented at the annual National Cancer Research Institute (NCRI) Cancer Conference in Liverpool which starts tomorrow.

5 Nov 2011

Education for women, girls a more effective strategy than family planning to solve global problems

In a post in the National Review's "The Corner," Christopher White, international director of operations for the World Youth Alliance, responds to a New York Times opinion piece published Wednesday in which columnist Nicholas Kristof hailed family planning as a solution to "many of the global problems that confront us."

5 Nov 2011

New UBC technology can accurately detect brain aneurysms

University of British Columbia researchers have developed new technology for monitoring brain aneurysms - an approach that is potentially less invasive and more accurate than current methods, and one that is simple enough for patients to use at home for frequent monitoring.

5 Nov 2011

Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. today announced positive data from its 72-patient, Phase 2 clinical trial with RGN-259, a sterile, preservative-free eye drop, to evaluate its safety and efficacy for the treatment of signs and symptoms of dry eye syndrome over a treatment period of 30 days using the Controlled Adverse Environment (CAE) model.

5 Nov 2011

Viewpoints: Romney's plan to cut the debt; congressional squabbles on spending; spurning insurers' concerns about new labels

First, eliminate every government program that is not absolutely essential. There are many things government does that we may like but that we do not need. … For example: Repeal ObamaCare, which would save $95 billion in 2016. …Eliminate Title X family planning programs benefiting abortion groups like Planned Parenthood. … Second, return federal programs to the states where innovation, cost management and reduction of fraud and abuse can far exceed what Washington achieves. I will block grant Medicaid and workforce training, saving well over $100 billion in 2016.

5 Nov 2011

Osiris Therapeutics third quarter revenues decrease marginally to $10.6 million

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory and cardiovascular disease areas and wound healing, announced today its results for the third quarter ended September 30, 2011.

4 Nov 2011

Experts look to India to develop accurate, affordable TB diagnostics

SciDev.Net examines tuberculosis (TB) in India, which has the world's highest TB burden, and some experts' hopes that researchers in the country can develop accurate and affordable diagnostic test kits.

4 Nov 2011

GTx third quarter net loss increases to $9.3 million

GTx, Inc. today reported financial results for the third quarter of 2011. The net loss for the quarter ended September 30, 2011 was $9.3 million compared with a net loss of $8.6 million for the quarter ended September 30, 2010, reflecting increased research and development costs in connection with the Company's Ostarine™ and Capesaris™ clinical development programs.

4 Nov 2011

Global Fund releases additional audits as part of internal investigation

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday posted the results of several internal audits, showing "that 12 more probes had turned up an additional $20 million of mismanagement, alleged fraud and misspending," the Associated Press/CBSNews.com reports.

4 Nov 2011

'Medicine that grows' confronts antibiotics resistance

It's been called "the trots," "Montezuma's Revenge," "the runs" and worse. But no matter the name, when it strikes, victims wish for a medicine that could go straight to the offending bacteria to quickly knock it dead.

4 Nov 2011

Acorda third quarter GAAP net income increases to $18.9 million

Acorda Therapeutics, Inc. today announced its financial results for the third quarter ended September 30, 2011.

4 Nov 2011

100 House lawmakers urge super committee to consider 'all options'

A letter from this bipartisan group of House members to the deficit panel asked that the super committee strive for a larger, $4 trillion deal. Meanwhile, Politico offers four possible scenarios that could play out.

4 Nov 2011

AMAG reports third quarter total revenues of $17.6 million

AMAG Pharmaceuticals, Inc. today reported unaudited consolidated financial results for the third quarter ended September 30, 2011.

4 Nov 2011

Quanticel, Celgene and Versant enter collaboration to discover and develop first-in-class cancer drugs

Privately held biotechnology company Quanticel Pharmaceuticals Inc. and Celgene Corporation, together with Versant Ventures, today announced they have entered into an exclusive, strategic collaboration to discover and develop first-in-class cancer drugs.

4 Nov 2011

First Edition: November 4, 2011

In today's headlines, reports about the super committee's apparent impasse, and details on Mitt Romney's plan to cut the deficit.

4 Nov 2011

Stimulus funds will help build health IT systems, but not sustain them

iWatch News reports on how this finding is raising concern among state officials about how they will keep paying for these systems when the federal money is gone. Meanwhile, KHN - in partnership with NPR and Oregon Public Radio - takes a look at how electronic medical records can be used.

4 Nov 2011

New technologies could aid in malignant melanoma diagnosis and therapy

Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.

4 Nov 2011

Research News and Research

First U.S. transcatheter aortic heart valve implant performed at NewYork-Presbyterian/Columbia

Toxoplasma gondii directly affects production of dopamine in brain

Rothman researchers to develop gold standard definition for periprosthetic joint infection

Study finds increase in cervical cancer incidence among young British women

Education for women, girls a more effective strategy than family planning to solve global problems

New UBC technology can accurately detect brain aneurysms

Positive data from RegeneRx RGN-259 Phase 2 trial on dry eye syndrome

Viewpoints: Romney's plan to cut the debt; congressional squabbles on spending; spurning insurers' concerns about new labels

Osiris Therapeutics third quarter revenues decrease marginally to $10.6 million

Experts look to India to develop accurate, affordable TB diagnostics

GTx third quarter net loss increases to $9.3 million

Global Fund releases additional audits as part of internal investigation

'Medicine that grows' confronts antibiotics resistance

Acorda third quarter GAAP net income increases to $18.9 million

100 House lawmakers urge super committee to consider 'all options'

AMAG reports third quarter total revenues of $17.6 million

Quanticel, Celgene and Versant enter collaboration to discover and develop first-in-class cancer drugs

First Edition: November 4, 2011

Stimulus funds will help build health IT systems, but not sustain them

New technologies could aid in malignant melanoma diagnosis and therapy

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery